| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPI
|
alkaline phosphatase, intestinal
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
ANGPT1
|
angiopoietin 1
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANXA1
|
annexin A1
|
|
APCDD1
|
adenomatosis polyposis coli down-regulated 1
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLP1
|
amyloid beta (A4) precursor-like protein 1
|
|
APOB
|
apolipoprotein B
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BID
|
BH3 interacting domain death agonist
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCHCR1
|
coiled-coil alpha-helical rod protein 1
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD163
|
CD163 molecule
|
|
CD209
|
CD209 molecule
|
|
CD248
|
CD248 molecule, endosialin
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD86
|
CD86 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC42
|
cell division cycle 42
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX4
|
caudal type homeobox 4
|
|
CDY2A
|
chromodomain protein, Y-linked, 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CFDP1
|
craniofacial development protein 1
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHGA
|
chromogranin A
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLDN5
|
claudin 5
|
|
CLDN6
|
claudin 6
|
|
CLDN9
|
claudin 9
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBA1
|
crystallin, beta A1
|
|
CRYBB1
|
crystallin, beta B1
|
|
CRYGS
|
crystallin, gamma S
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTSC
|
cathepsin C
|
|
CTSD
|
cathepsin D
|
|
CTSG
|
cathepsin G
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DENND1A
|
DENN/MADD domain containing 1A
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSG1
|
desmoglein 1
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENSA
|
endosulfine alpha
|
|
EPHB6
|
EPH receptor B6
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FBLN1
|
fibulin 1
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXJ1
|
forkhead box J1
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GCG
|
glucagon
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLCE
|
glucuronic acid epimerase
|
|
GNAS
|
GNAS complex locus
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPHN
|
gephyrin
|
|
GPM6A
|
glycoprotein M6A
|
|
GPR1
|
G protein-coupled receptor 1
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
|
GRP
|
gastrin-releasing peptide
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCAR3
|
hydroxycarboxylic acid receptor 3
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HDGFL1
|
hepatoma derived growth factor-like 1
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST2H3A
|
histone cluster 2, H3a
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HPSE
|
heparanase
|
|
HRH1
|
histamine receptor H1
|
|
HRH4
|
histamine receptor H4
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HSFY1
|
heat shock transcription factor, Y-linked 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA21
|
interferon, alpha 21
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KNG1
|
kininogen 1
|
|
KRT10
|
keratin 10, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRTAP24-1
|
keratin associated protein 24-1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB3
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene)
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR1291
|
microRNA 1291
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR133A2
|
microRNA 133a-2
|
|
MIR135B
|
microRNA 135b
|
|
MIR145
|
microRNA 145
|
|
MIR155
|
microRNA 155
|
|
MIR203A
|
microRNA 203a
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR34A
|
microRNA 34a
|
|
MIR5739
|
microRNA 5739
|
|
MIR675
|
microRNA 675
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLANA
|
melan-A
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MPP5
|
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSN
|
moesin
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRNR2L1
|
MT-RNR2-like 1
|
|
MTRNR2L10
|
MT-RNR2-like 10
|
|
MTRNR2L2
|
MT-RNR2-like 2
|
|
MTRNR2L3
|
MT-RNR2-like 3
|
|
MTRNR2L4
|
MT-RNR2-like 4
|
|
MTRNR2L5
|
MT-RNR2-like 5
|
|
MTRNR2L6
|
MT-RNR2-like 6
|
|
MTRNR2L7
|
MT-RNR2-like 7
|
|
MTRNR2L8
|
MT-RNR2-like 8
|
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAA35
|
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
|
|
NANOG
|
Nanog homeobox
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NES
|
nestin
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NKX6-1
|
NK6 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPPC
|
natriuretic peptide C
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRG1
|
neuregulin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NSFL1C
|
NSFL1 (p97) cofactor (p47)
|
|
NTF3
|
neurotrophin 3
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUP107
|
nucleoporin 107kDa
|
|
NUP133
|
nucleoporin 133kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OSM
|
oncostatin M
|
|
OTX1
|
orthodenticle homeobox 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPD4
|
PAP associated domain containing 4
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARN
|
poly(A)-specific ribonuclease
|
|
PAX2
|
paired box 2
|
|
PDCD1
|
programmed cell death 1
|
|
PDCL
|
phosducin-like
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PDSS2
|
prenyl (decaprenyl) diphosphate synthase, subunit 2
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PELI3
|
pellino E3 ubiquitin protein ligase family member 3
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PITPNM3
|
PITPNM family member 3
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLG
|
plasminogen
|
|
PML
|
promyelocytic leukemia
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRG4
|
proteoglycan 4
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRL
|
prolactin
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRPF8
|
pre-mRNA processing factor 8
|
|
PSEN2
|
presenilin 2
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
PXN
|
paxillin
|
|
RAB11B
|
RAB11B, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB32
|
RAB32, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL4
|
RecQ protein-like 4
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETNLB
|
resistin like beta
|
|
RHOD
|
ras homolog family member D
|
|
RPS19
|
ribosomal protein S19
|
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
|
RUSC2
|
RUN and SH3 domain containing 2
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SASS6
|
spindle assembly 6 homolog (C. elegans)
|
|
SATB1
|
SATB homeobox 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMG1
|
semenogelin I
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SF3B6
|
splicing factor 3b, subunit 6, 14kDa
|
|
SFTPA1
|
surfactant protein A1
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD1
|
SMAD family member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMTN
|
smoothelin
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPX
|
spexin hormone
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
SUPT7L
|
suppressor of Ty 7 (S. cerevisiae)-like
|
|
SYCP1
|
synaptonemal complex protein 1
|
|
TAS2R16
|
taste receptor, type 2, member 16
|
|
TBC1D3C
|
TBC1 domain family, member 3C
|
|
TBX3
|
T-box 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
THADA
|
thyroid adenoma associated
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THOP1
|
thimet oligopeptidase 1
|
|
THPO
|
thrombopoietin
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIPE2
|
TNF alpha induced protein 8 like 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TLX2
|
T-cell leukemia homeobox 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOR1B
|
torsin family 1, member B (torsin B)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPST2
|
tyrosylprotein sulfotransferase 2
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRO
|
trophinin
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTR
|
transthyretin
|
|
TXN
|
thioredoxin
|
|
TXN2
|
thioredoxin 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
VAPA
|
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VSX2
|
visual system homeobox 2
|
|
VWF
|
von Willebrand factor
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor)
|
